Investments
103Portfolio Exits
19Funds
5About M Ventures
M Ventures backs entrepreneurs through equity investments and hands-on support in fields that could impact the vitality and sustainability of Merck Group (FWB: MRK), Darmstadt, Germany's current and future businesses. M Ventures is the strategic, corporate venture capital arm of Merck Group, Darmstadt, Germany. Its mandate is to invest in technologies and products with the potential to significantly impact Merck Group, Darmstadt, Germany's core business areas. From its headquarters in Amsterdam and offices in the US and Israel the firm invests globally in transformational ideas driven by great entrepreneurs. M Ventures takes an active role in portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. The firm has a significant focus on early-stage investing and company creation, including the creation of spin-offs to leverage Merck KGaA, Darmstadt, Germany's science and technology base.
Want to inform investors similar to M Ventures about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest M Ventures News
Aug 28, 2023
beeOLED , a Dresden, Germany-based deep-tech startup, raised EUR 13.3m in Series A funding. The round was co-led by eCAPITAL and Innovation Industries with participation from KBC Focus Fund, as well as existing investors M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, Germany), HTGF, TGFS, and JBN-Invest. The company intends to use the funds to further develop its deep-blue emitter technology towards go-to-market-readiness. Co-founded in 2020 by Carsten Rothe, Volodymyr Senkovskyy, and Jan Blochwitz-Nimoth, beeOLED develops an efficient & stable deep-blue emitter to improve displays in phones, tablets, laptops, TVs and other displays. Its technology, based on making elementary emission from atoms, fit for use in today’s vacuum processed OLED displays. Its intra-metallic emission technology integrates into existing OLED structures and established OLED display manufacturing technology. It allows for 100 percent internal quantum efficiency, a prerequisite for the highest power efficiency in OLED displays. FinSMEs
M Ventures Investments
103 Investments
M Ventures has made 103 investments. Their latest investment was in NeoLogic as part of their Seed VC - II on July 7, 2023.
M Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
7/26/2023 | Seed VC - II | NeoLogic | $8M | Yes | 2 | |
6/27/2023 | Seed VC | Astraveus | $18.03M | Yes | 2 | |
4/13/2023 | Series B | Celestial AI | $100M | No | 5 | |
2/16/2023 | Seed VC | |||||
1/25/2023 | Series B |
Date | 7/26/2023 | 6/27/2023 | 4/13/2023 | 2/16/2023 | 1/25/2023 |
|---|---|---|---|---|---|
Round | Seed VC - II | Seed VC | Series B | Seed VC | Series B |
Company | NeoLogic | Astraveus | Celestial AI | ||
Amount | $8M | $18.03M | $100M | ||
New? | Yes | Yes | No | ||
Co-Investors | |||||
Sources | 2 | 2 | 5 |
M Ventures Portfolio Exits
19 Portfolio Exits
M Ventures has 19 portfolio exits. Their latest portfolio exit was Bird Rock Bio on August 21, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
8/21/2023 | Acquired | 2 | |||
6/1/2023 | Acquired | 8 | |||
9/22/2022 | Acquired | 6 | |||
Date | 8/21/2023 | 6/1/2023 | 9/22/2022 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 2 | 8 | 6 |
M Ventures Fund History
5 Fund Histories
M Ventures has 5 funds, including M Ventures.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/8/2021 | M Ventures | $676.4M | 1 | ||
10/18/2019 | China Seed Fund | ||||
11/3/2017 | Merck-CDRD Innovation Fund | ||||
MS Ventures II | |||||
ExploreBio |
Closing Date | 12/8/2021 | 10/18/2019 | 11/3/2017 | ||
|---|---|---|---|---|---|
Fund | M Ventures | China Seed Fund | Merck-CDRD Innovation Fund | MS Ventures II | ExploreBio |
Fund Type | |||||
Status | |||||
Amount | $676.4M | ||||
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
